May 17, 2020

Carillion crisis – what next for companies in its supply chain?

Carillion
carillion collapse
carillion supply chain
UK
James Henderson
4 min
What can companies do about the collapse of UK construction group Carillion?
The collapse of construction giant Carillion has sent shockwaves through the construction industry and beyond, with costs to its supply chain likely to...

The collapse of construction giant Carillion has sent shockwaves through the construction industry and beyond, with costs to its supply chain likely to run into billions of pounds.

Companies that are owed money from Carillion face a tense wait to find out whether they are eligible to receive funds as part of a potential package put together by the UK Government.

The Government has come in for heavy criticism from industry observers who point to contracts that were awarded to Carillion even after the troubled company has issued two profit warnings.

“One of the major criticisms the supply chain will level is that the Government led the industry into a false sense of security,” said Simon Coley, Director, Construction Risk at Nucleus Commercial Finance.

“In awarding Carillion a project such as HS2 despite Carillion having received three profit warnings in the 12 months previous, the government’s vote of confidence had a significant knock-on effect of potentially lulling suppliers and contractors in to committing to projects with them.”

Ian McIlwee, CEO of British Woodworking Federation believes the Government must take its fair share of the blame for what he calls a “sorry saga” and has urged it to provide security against “unjust payment clauses”.

“This debate is not about whether the state should bail out Carillion, but whether Government can in all conscience turn its back on a supply chain of SMEs who will end up carrying the can for poor procurement, bad business management and an endemic failure by the Government to address some of the archaic procurement practices surrounding late payments and retentions that place risk unfairly on SME sub-contractors,” he said.

“Many of the creditors are SMEs and the sums, whilst likely to be significantly lower than the liquidators will take, could define the future of these businesses - it would be a gross injustice if their money unfairly held is lost in this process.”

Such a decision could put companies in Carillion’s supply chain in a precarious spot, but John Buchanan of chartered accountants, H W Fisher & Company, says that businesses must try to take charge of the situation.

“Those companies that have been supplying goods or services need to claim for their retention payments right away as if they are being used by the official receivers or special managers, they need to be paid for,” he says.

“We would encourage companies to speak with the special managers and receivers to find out what the implications are for them. Some contracts will have to continue, and companies will find they’re going to be requested to provide ongoing supplies.

“If it’s something only they can supply, they could be in a position to ask for full debts to be paid before they supply any further.”

SEE ALSO:

But, says Buchanan, a number of companies are going to be hit hard by the collapse of Carillion, and they will need to take professional advice as soon as possible.

“There is potential for a domino effect,” he comments. “One insolvency can cause many others, especially when a company of this size falls. I think what has happened is quite unprecedented and shows that companies are not too big to fail.”

Simon Renshaw, Insolvency Practitioner for AABRS.com, says that with over 450 public sector contracts, there is “no doubt that Carillion’s collapse is going to have a seismic effect on the wider business community”.

“Whilst the government is saying it's business as usual and urging Carillion's 20,000 odd staff to attend work, it is going to take months and possibly years for the full ramifications of the collapse to unravel.

“Of immediate concern is the HS2 rail link, for which Carillion was set to play an integral part: currently, the Prime Minister's spokesman has suggested these building contracts will remain in the private sector. Additionally, Balfour Beatty is going to feel this, to the tune of some £45m by initial estimates.

“Of real concern for the wider British business community, however, is how this is going affect the wider supply chain. Many smaller firms could find themselves at grave risk of following Carillion into liquidation.”

With the Government facing calls to re-think how it awards multi-billion-pound contracts, Alex Saric, CMO at Ivalua says that lessons must be learnt from the current crisis.

“When working with suppliers, it’s important that public sector organisations have complete visibility into the potential risks as part of the procurement process. Are your suppliers working ethically, do they have the ability to deliver the work and are they financially stable?

“Without this information how can public sector agencies ensure value for the taxpayer? The pressure is now on for those involved in the public sector projects impacted to quickly assess and onboard new suppliers as quickly as possible.”

Share article

Jun 11, 2021

NTT DATA Services, Remodelling Supply Chains for Resilience

NTTDATA
supplychain
Supplychainriskmanagement
Procurement
6 min
Joey Dean, Managing Director of healthcare consulting at NTT DATA Services, shares remodelling strategies for more resilient supply chains

Joey Dean, the man with the coolest name ever and Managing Director in the healthcare consulting practice for NTT DATA and is focused on delivering workplace transformation and enabling the future workforce for healthcare providers. Dean also leads client innovation programs to enhance service delivery and business outcomes for clients.

The pandemic has shifted priorities and created opportunities to do things differently, and companies are now looking to build more resilient supply chains, none needed more urgently than those within the healthcare system. Dean shares with us how he feels they can get there.

A Multi-Vendor Sourcing Approach

“Healthcare systems cannot afford delays in the supply chain when there are lives at stake. Healthcare procurement teams are looking at multi-vendor sourcing strategies, stockpiling more inventory, and ways to use data and AI to have a predictive view into the future and drive greater efficiency.

“The priority should be to shore up procurement channels and re-evaluate inventory management norms, i.e. stockpiling for assurance. Health systems should take the opportunity to renegotiate with their current vendors and broaden the supplier channel. Through those efforts, work with suppliers that have greater geographic diversity and transparency around manufacturing data, process, and continuity plans,” says Dean.

But here ensues the never-ending battle of domestic vs global supply chains. As I see it, domestic sourcing limits the high-risk exposure related to offshore sourcing— Canada’s issue with importing the vaccine is a good example of that. So, of course, I had to ask, for lifesaving products, is building domestic capabilities an option that is being considered?

“Domestic supply chains are sparse or have a high dependence on overseas centres for parts and raw materials. There are measures being discussed from a legislative perspective to drive more domestic sourcing, and there will need to be a concerted effort by Western countries through a mix of investments and financial incentives,” Dean explains.

Wielding Big Tech for Better Outcomes

So, that’s a long way off. In the meantime, leveraging technology is another way to mitigate the risks that lie within global supply chains while decreasing costs and improving quality. Dean expands on the potential of blockchain and AI in the industry

“Blockchain is particularly interesting in creating more transparency and visibility across all supply chain activities. Organisations can create a decentralised record of all transactions to track assets from production to delivery or use by end-user. This increased supply chain transparency provides more visibility to both buyers and suppliers to resolve disputes and build more trusting relationships. Another benefit is that the validation of data is more efficient to prioritise time on the delivery of goods and services to reduce cost and improve quality. 

“Artificial Intelligence and Machine Learning (AI/ML) is another area where there’s incredible value in processing massive amounts of data to aggregate and normalise the data to produce proactive recommendations on actions to improve the speed and cost-efficiency of the supply chain.”

Evolving Procurement Models 

From asking more of suppliers to beefing up stocks, Dean believes procurement models should be remodelled to favour resilience, mitigate risk and ensure the needs of the customer are kept in view. 

“The bottom line is that healthcare systems are expecting more from their suppliers. While transactional approaches focused solely on price and transactions have been the norm, collaborative relationships, where the buyer and supplier establish mutual objectives and outcomes, drives a trusting and transparent relationship. Healthcare systems are also looking to multi-vendor strategies to mitigate risk, so it is imperative for suppliers to stand out and embrace evolving procurement models.

“Healthcare systems are looking at partners that can establish domestic centres for supplies to mitigate the risks of having ‘all of their eggs’ in overseas locations. Suppliers should look to perform a strategic evaluation review that includes a distribution network analysis and distribution footprint review to understand cost, service, flexibility, and risks. Included in that strategy should be a “voice of the customer” assessment to understand current pain points and needs of customers.”

“Healthcare supply chain leaders are re-evaluating the Just In Time (JIT) model with supplies delivered on a regular basis. The approach does not require an investment in infrastructure but leaves organisations open to risk of disruption. Having domestic centres and warehousing from suppliers gives healthcare systems the ability to have inventory on hand without having to invest in their own infrastructure. Also, in the spirit of transparency, having predictive views into inventory levels can help enable better decision making from both sides.”

But, again, I had to ask, what about the risks and associated costs that come with higher inventory levels, such as expired product if there isn’t fast enough turnover, tying up cash flow, warehousing and inventory management costs?

“In the current supply chain environment, it is advisable for buyers to carry an in-house inventory on a just-in-time basis, while suppliers take a just-in-case approach, preserving capacity for surges, retaining safety stock, and building rapid replenishment channels for restock. But the risk of expired product is very real. This could be curbed with better data intelligence and improved technology that could forecast surges and predictively automate future supply needs. In this way, ordering would be more data-driven and rationalised to align with anticipated surges. Further adoption of data and intelligence and will be crucial for modernised buying in the new normal.

The Challenges

These are tough tasks, so I asked Dean to speak to some of the challenges. Luckily, he’s a patient guy with a lot to say.

On managing stakeholders and ensuring alignment on priorities and objectives, Dean says, “In order for managing stakeholders to stay aligned on priorities, they’ll need more transparency and collaborative win-win business relationships in which both healthcare systems and medical device manufacturers are equally committed to each other’s success. On the healthcare side, they need to understand where parts and products are manufactured to perform more predictive data and analytics for forecasting and planning efforts. And the manufacturers should offer more data transparency which will result in better planning and forecasting to navigate the ebbs and flows and enable better decision-making by healthcare systems.

Due to the sensitive nature of the information being requested, the effort to increase visibility is typically met with a lot of reluctance and push back. Dean essentially puts the onus back on suppliers to get with the times. “Traditionally, the relationships between buyers and suppliers are transactional, based only on the transaction between the two parties: what is the supplier providing, at what cost, and for what length of time. The relationship begins and ends there. The tide is shifting, and buyers expect more from their suppliers, especially given what the pandemic exposed around the fragility of the supply chain. The suppliers that get ahead of this will not only reap the benefits of improved relationships, but they will be able to take action on insights derived from greater visibility to manage risks more effectively.”

He offers a final tip. “A first step in enabling a supply chain data exchange is to make sure partners and buyers are aware of the conditions throughout the supply chain based on real-time data to enable predictive views into delays and disruptions. With well understand data sets, both parties can respond more effectively and work together when disruptions occur.”

As for where supply chain is heading, Dean says, “Moving forward, we’ll continue to see a shift toward Robotic Process Automation (RPA), Artificial Intelligence (AI), and advanced analytics to optimise the supply chain. The pandemic, as it has done in many other industries, will accelerate the move to digital, with the benefits of improving efficiency, visibility, and error rate. AI can consume enormous amounts of data to drive real-time pattern detection and mitigate risk from global disruptive events.”

 

Share article